Sigma-Aldrich Enters Agreement with Novatia
Sigma-Genosys, a division of Sigma-Aldrich, acquires Novatia’s cutting edge Oligo HTCS system for characterization of synthetic oligonucleotides. See the full press release here.
Sigma-Genosys, a division of Sigma-Aldrich, acquires Novatia’s cutting edge Oligo HTCS system for characterization of synthetic oligonucleotides. See the full press release here.